# The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants

> **NCT00964093** · NA · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 100 (actual)

## Conditions studied

- Central Line Bloodstream Infections

## Interventions

- **DEVICE:** Silver Alginate

## Key facts

- **NCT ID:** NCT00964093
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11-23
- **Primary completion:** 2014-08-25
- **Final completion:** 2015-08-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964093, "The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00964093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*